This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Ken-ichi Kazuta: Innovator in Central Nervous System Treatments
Ken-ichi Kazuta is a distinguished inventor based in Ibaraki, Japan, known for his significant contributions to pharmaceutical innovations. With one patent to his name, Kazuta has focused on developing treatments that address critical health issues.
Latest Patents
Kazuta's notable patent revolves around a tricyclic pyrrole or pyrazole derivative, which is represented by the general formula (I). This innovative compound demonstrates strong affinity and selectivity for the 5-HT receptor, making it particularly useful in addressing various central nervous system disorders. These include sexual disorders, eating disorders, anxiety, depression, and sleeping disorders. The impact of his invention could lead to improved therapeutic options for patients suffering from these conditions.
Career Highlights
Kazuta has made significant strides in his career, primarily through his role at Yamanouchi Pharmaceutical Company Ltd. His work there has been instrumental in advancing research and development in the field of psychiatry and neurology. Kazuta's dedication to his craft has positioned him as a valued contributor to the pharmaceutical landscape.
Collaborations
Throughout his career, Ken-ichi Kazuta has collaborated with notable colleagues, including Kyoichi Maeno and Hideki Kubota. These partnerships have fostered a creative environment and have led to influential discoveries and innovations in pharmaceutical applications. The collaborative efforts of these professionals have enhanced the potential for developing effective treatments for various disorders.
Conclusion
In summary, Ken-ichi Kazuta exemplifies the spirit of innovation within the pharmaceutical industry. With his groundbreaking patent targeting central nervous system disorders, he has positioned himself as a key figure in the quest for better health solutions. As research continues to evolve, Kazuta's contributions and collaborations will undoubtedly remain influential in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile